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Stem cell-based regenerative medicine is one of the most intensively researched medical issues. Pre-clinical studies in a large-animal model, especially in swine or miniature 
pigs, are highly relevant to human applications. Mesenchymal stem cells (MSCs) have been 
isolated and expanded from different sources. Objective: This study aimed at isolating and 
characterizing, for the first time, bone marrow-derived MSCs (BM-MSCs) from a Brazilian 
minipig (BR1). Also, this aimed to validate a new large-animal model for stem cell-based 
tissue engineering. Material and Methods: Bone marrow (BM) was aspirated from the 
posterior iliac crest of twelve adult male BR1 under general anesthesia. MSCs were selected 
by plastic-adherence as originally described by Friedenstein. Cell morphology, surface 
marker expression, and cellular differentiation were examined. The immunophenotypic 
profile was determined by flow cytometry. The differentiation potential was assessed by 
cytological staining and by RT-PCR. Results: MSCs were present in all minipig BM samples. 
These cells showed fibroblastic morphology and were positive for the surface markers CD90 
(88.6%), CD29 (89.8%), CD44 (86.9%) and negative for CD34 (1.61%), CD45 (1.83%), 
CD14 (1.77%) and MHC-II (2.69%). MSCs were differentiated into adipocytes, osteoblasts, 
and chondroblasts as demonstrated by the presence of lipidic-rich vacuoles, the mineralized 
extracellular matrix, and the great presence of glycosaminoglycans, respectively. The 
higher gene expression of adipocyte fatty-acid binding protein (AP2), alkaline phosphatase 
(ALP) and collagen type 2 (COLII) also confirmed the trilineage differentiation (p<0.001, 
p<0.001, p=0.031; respectively). Conclusions: The isolation, cultivation, and differentiation 
of BM-MSCs from BR1 makes this animal eligible as a useful large-animal model for stem 
cell-based studies in Brazil. 
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INTRODUCTION
Although in vivo experiments using small 
animals provide the therapeutic potential of 
a treatment, there exist many fundamental 
differences between the small animal and the 
human10. Before applying the therapy to clinical 
patients, large animal studies, especially in swine 
or miniature pigs, are a prerequisite to validate the 
efficacy in an animal model more relevant to the 
human10,17. Previous studies have demonstrated 
that the minipig represents a suitable large animal 
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model for preclinical testing of different diseases 
and treatments1,11.
Mesenchymal stem cells (MSCs) were first 
described by Fridenstein, et al. in 1976 as the 
clonal, plastic adherent cells, being a source of 
the osteoblastic, adipogenic and chondrogenic cell 
lines5. MSCs are non-hematopoietic cells, which 
are present in a variety of tissues, being more 
prevalent in the bone marrow (BM) compartment, 
playing a key role in the maintenance of BM 
homeostasis and regulate the maturation of both 
hematopoietic and non-hematopoietic cells14.
The isolation and the expansion of porcine MSCs 
(pMSCs) from different tissues have been relatively 
easy due to their adherence to culture plastic, 
fibroblastic morphology, self-renewal, proliferation, 
and in-vitro tri-lineage differentiation (adipogenic, 
chondrogenic, and osteogenic)3,4,17,20.
As reported previously, the techniques used for 
isolation, expansion, osteogenic, chondrogenic, 
and adipogenic differentiation of human MSCs can 
be adopted for analysis of pMSC, which may serve 
the increasing demand for stem and progenitor 
cells in tissue engineering1,11,17. 
In Brazil, the minipig BR-1 is the only Brazilian’s 
miniature pig, developed exclusively for research. 
This paper aimed at isolating and characterizing BM-
MSCs from BR1 to validate this new large-animal 
model for stem cell-based tissue engineering in 
Brazil.
MATERIAL AND METhODS
Animals
Twelve adult male Brazilian miniature pigs (BR-
1) aged 18–24 months and weighing 30–40 kg 
(Figure 1) (MINIPIG Research and Development, 
Campina do Monte Alegre, SP, Brazil) were used 
in the present study. The ethics and Research 
Committee at Positivo University, Curitiba, 
Paraná, Brazil, approved this study (protocol 
001/2009). The experimental procedures and 
care of the animals were conducted in accordance 
with the Law 11794/2008 of the Brazilian Federal 
Constitution, which regulates and establishes the 
“Procedures for the scientific use of animals”.
The animals were kept in the bioterium 
throughout the experiment in pre-cast bays, 
with enough space for two animals in each, at 
a temperature of 23±2°C, a relative humidity 
of 55±10%, a 12/12 h dark/light cycle, and at 
hygienic conditions. The animals were fed twice a 
day with appropriated food (Presuntina Pro, Nestlé 
Purina, São Paulo, SP, Brazil) and water ad libitum.
Isolation, expansion and culture of BM-
pMSCs
For BM aspiration, animals received an 
intramuscular injection of a combination of 
ketamine hydrochloride 10% (10 mg/kg) and 
xylazine hydrochloride 2% (5 mg/kg), followed by 
intravenous administration of sodium pentobarbital 
5% (5 mg/kg). From each animal, a total of 20 
mL of fresh heparinized BM was aspirated from 
posterior iliac crest using a Jamishidi needle 
(Raiomedic, São José dos Pinhais, PR, Brazil). The 
samples were added into Dulbecco’s modified Eagle 
medium (DMeM) (Gibco® Invitrogen, Grand Island, 
NY, USA) supplemented with 100 U/mL penicillin, 
100 μg/mL streptomycin (Gibco® Invitrogen, Grand 
Island, NY, USA), and 50 IU/mL heparin (Cristália, 
São Paulo, SP, Brazil). Mononuclear cells were 
isolated by Ficoll-Hypaque (Sigma-Aldrich Corp, 
St. Louis, MO, USA) density gradient centrifugation 
(d=1,077 g/cm3)20. After centrifugation at 400 xg 
for 30 min at room temperature, mononuclear 
cells, which were situated in an opalescent layer 
between the gradient and blood plasma, were 
retrieved and washed in DMeM supplemented with 
1% antibiotics. The number of mononuclear cells 
was counted and the cell viability was assessed.
Mononuclear cells were resuspended in DMeM 
supplemented with 15% fetal bovine serum (FBS), 
100 U/mL penicillin, and 100 μg/mL streptomycin, 
plated on 75 cm2 flasks (TPP, TRA, Switzerland) 
at a density of approximately 1x105 cells/cm2 and 
Figure 1- Adult male Brazilian miniature pigs (BR-1)
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incubated in a humidified 5% CO2 atmosphere 
at 37°C (Thermo Forma Series II, Marietta, 
Ohio, USA). After 48 hours, the non-adherent 
cells were discarded and the adherent cells were 
cultured at the same conditions until 80–90% 
of confluence. Cells were detached using 0.25% 
trypsin-ethylenediamine tetraacetic acid solution 
(Trypsin-eDTA) (Gibco® Invitrogen, Grand Island, 
NY, USA) for 4 min at 37°C, washed twice with 
phosphate-buffered saline (PBS) (0.01 M, pH 
7.2) (Gibco® Invitrogen, Grand Island, NY, USA), 
centrifuged at 400 g for 10 min, and resuspended 
in the same culture conditions (passage 1). The 
cells were plated at a density of 4x103 cells/cm2. 
Media change was carried out every three days. 
The BM-pMSCs were expanded until passage 
4, when the immunophenotypic profile was 
characterized by flow cytometry and the in vitro 
differentiation was performed. In each passage, 
the number of MSCs was counted and the cell 
viability was assessed. Cells were continuously 
observed until passage 4 by light microscopy to 
evaluate cell morphology, the lack of proliferation 
signs and the cell death ratio.
Cell viability
The cell number and the viability were evaluated 
in each passage. Briefly, 50 µL of cell suspension 
were added to 10 µL of the Trypan Blue 0.4% dye 
(Sigma Aldrich, St. Louis, MO, USA) during five 
minutes. Using a Neubauer chamber in a light 
microscope, the total numbers of live and dead 
cells (blue cells) were counted and the percentage 
of viable cells was calculated. 
Flow cytometry
Immunophenotypic analyses were performed 
by staining approximately 5x105 cells with 
unconjugated monoclonal antibodies against pig 
antigens. At passage 4, undifferentiated BM-pMSCs 
were detached using 0.25% trypsin-eDTA and 
labeled with unconjugated monoclonal antibodies 
against swine cluster of differentiation (CD) 
antigens CD14 (CAM36A), CD44 (PORC24A), CD45 
(74-9-3A1), CD29 (FW4-101) and MHC-II (MSA3) 
(all from VMRD Inc., Pullman, WA, USA). Briefly, 
cells were detached, washed with PBS (Gibco® 
Invitrogen, Grand Island, NY, USA), incubated with 
antibodies for 15 minutes on ice, washed again for 
three times, and then further incubated with an 
isotype-specific phycoeritrin (PE) conjugated rat 
anti-mouse (BD Biosciences, Seattle, WA, USA) 
for another 15 minutes. The cells were washed 
with PBS and resuspended in 500 µL of PBS with 
1% of formaldehyde (Gibco® Invitrogen, Grand 
Island, NY, USA). Mouse isotype IgG1 antibody 
was used as control (BD Pharmingen, San Jose, 
CA, USA). The cells were also stained with mouse 
anti-human CD90 and CD34 both Pe conjugated 
(BD Biosciences, Seattle, WA, USA).
7-AAD viability dye solution was used to 
discriminate viable from non-viable cells (BD 
Biosciences, San Jose, CA, USA). Cells were 
washed with PBS, incubated with dye solution for 
30 minutes, washed again, and resuspended in 
500 µL of PBS with 1% of formaldehyde (Sigma-
Aldrich Corp, St. Louis, MO, USA). Not all lineage 
phenotypes could be examined because of the 
limited availability of commercial antibodies 
working in pig immunostaining. For this reason, 
we used anti-human CD90 and CD34.
Approximately 100,000 events were acquired 
using a FACS Calibur flow cytometer (Becton & 
Dickinson Company, Franklin Lakes, NJ, USA) and 
analyzed with the FlowJo software (TreeStar Inc., 
Ashland, OR, USA).
In vitro pMSCs differentiation
The in vitro differentiations of BM-pMSCs were 
evaluated in triplicates by culturing cells from 
passage 4 in a commercial media. The control 
ones were cultured in DMeM with 15% FBS for 
the same period.
Approximately 15x103 pMSCs were plated 
on glass coverslips (Sarstedt Group, Newton, 
NC, USA) in 24-well plates (TPP Techno Plastic 
Products, Trasadingen, Switzerland) in a DMeM 
with 15% FBS. When the cell confluence was 
approximately 80%, the medium was replaced 
with the osteogenic medium (StemPro® Osteogenic 
Differentiation Basal Medium, Gibco® Invitrogen, 
Grand Island, NY, USA) or the adipogenic medium 
(StemPro® Adipogenic Differentiation Basal 
Medium, Gibco® Invitrogen, Grand Island, NY, 
USA). Cells were fed with the fresh differentiation 
medium every 3 days for 21 days16.
For chondrogenic differentiation, cells were 
grown in micromass culture4,6. Briefly, 2x105 
cells in 0.5 mL of DMeM were centrifuged at 300 
g for 10 min in a 15 mL polypropylene tube to 
form a pellet. Without disturbing the pellet, cells 
were cultured for 21 days in an induced medium 
(StemPro® Chondrogenic Differentiation Basal 
Medium, Gibco® Invitrogen, Grand Island, NY, 
USA). Cells were fed with the fresh differentiation 
medium every 3 days for 21 days.
Alizarin red staining for mineralized matrix
Cells were fixed with 4% paraformaldehyde for 
5 min and washed with water three times, then 
the cells were incubated with alizarin red S at pH 
4.1 (Sigma-Aldrich Corp, St. Louis, MO, USA) for 
15 min at room temperature. Cells were washed 
with water several times prior to imaging.
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Oil red staining for cytoplasmic fat globules 
Cells were fixed with 4% paraformaldehyde for 
5 min and washed with water three times, then 
the cells were incubated for 10 min with a filtered 
0.5% Oil red (Sigma-Aldrich Corp, St. Louis, MO, 
USA) solution prepared in 60% isopropanol. Cells 
were washed with water several times prior to 
photographing.
Alcian blue staining for mucosubstances
Ce l l  aggregates  were  f ixed in  10% 
paraformaldehyde for 1 h at room temperature, 
dehydrated in serial ethanol dilutions, and 
embedded in paraffin blocks. Paraffin sections of 
4 µm of thickness were stained for histological 
analysis with Alcian Blue 8GX (Sigma-Aldrich Corp, 
St. Louis, MO, USA) solution prepared in 3% acetic 
acid. The samples were washed with water several 
times prior to imaging.
Reverse transcriptase-polymerase chain 
reaction (RT-PCR)
Osteogenic, adipogenic and chondrogenic 
differentiation were further confirmed by reverse 
transcriptase polymerase chain reaction (RT-PCR). 
BM-pMSCs cultured in DMeM with 15% FBS were 
used as control.
Total RNA was obtained with the RNeasy 
purification kit (QIAGEN, Austin, TX, USA) and 
treated in column with DNAse I (QIAGeN, Austin, 
TX, USA). Concentrations were determined by 
spectrophotometry (Gene-Quant, Amersham 
Biosciences, Sunnyvale, CA, USA). Complementary 
DNA (cDNA) was synthesized from 1 μg of 
total RNA by using 1 μl of 10 μM oligo-dT 
primer (USB Corporation, Cleveland, OH, USA) 
and 1 μl of reverse transcriptase (IMPROM II, 
Promega, Fitchburg, WI, USA) according to the 
manufacturers’ instructions.
RT-PCR was carried out with 20 ng of cDNA as 
template, 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 
5 pmol of primers (10 pmol for each gene), 2.5 
mM MgCl2, 0.0625 mM dNTPs, and 1 unit Taq 
polymerase (Gibco® Invitrogen, Grand Island, 
NY, USA). The primer sets used for PCR and 
the amplicon size are depicted in Figure 2. PCR 
included denature at 94°C for 2 minutes, and the 
heating was followed by 30 cycles of denature at 
94°C for 15 seconds, annealing for 30 seconds, 
extension at 72°C for 40 seconds, and a final 
extension of 72°C for 3 minutes by using a Bio-
Cycler II thermocycler (Peltier Thermal Cycler; 
Bio-Rad, Hercules, CA, USA). Ten microliters of 
RT-PCR products were analyzed by 2% agarose 
gel electrophoresis, visualized by ethidium bromide 
staining, and photographed under ultraviolet 
illumination (UV White Darkroom, UVP Bioimaging 
Systems, Upland, CA, USA). GAPDH was used 
as a housekeeping control. This experiment 
was performed with material from at least three 
animals, with technical triplicates. RT-PCR bands 
were analyzed by using ImageJ version 1.45d.
Target 
gene
Primer sequence Annealing Predicted 
Forward (5’- 3’) Reverse (3’- 5’) temperature (°C) size (bp)
GAPDH CTG CCC CTT CTG CTG ATG C GAC AAC TTC GGC ATC GTG GA 60 151
ALP ATG AGC TCA ACC GGA ACA A GTG CCC ATG GTC AAT CCT 56 131
AP2 GGC CAA ACC CAA CCT GA GGG CGC CTC CAT CTA AG 58 167
Col2 CTG GAG CTC CTG GCC TCG TG CAG ATG CGC CTT TGG GAC CAT 67.1 180
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; ALP: alkaline phosphatase; AP2: adipocyte protein 2; Col2: type 
2 collagen
Figure 2- Primer sequences and conditions used for reverse transcriptase-polymerase chain reaction (RT-PCR)
Figure 3- Morphology of MSCs-BM of Minipig BR-1: (A) 40x (B) 100x (C) 200x
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Statistical analysis
Statistical analysis was performed with SPSS 
17.0 (SPSS Inc., Chicago, IL, USA). All data 
were expressed as mean and standard deviation. 
Student’s t test was used to assess the significance 
of differences between the cell populations that 
were analyzed. P values ≤0.05 were considered 
to be statistically significant.
RESULTS
Porcine MSCs were successfully isolated from 
BM of all 12 animals. By day 3, cells adhered, 
and nonadherent hematopoietic cells present 
in the culture after initial plating were removed 
with sequential exchange of culture medium. 
After 4–5 days of culturing the first colonies of 
mononuclear cells were observed. Morphologically, 
pMSC appeared as single, stretched cells leading 
to large clusters of stellate cells as they multiplied. 
Around the 10th day, 80–90% of cell confluence 
was observed. MSCs attached to the culture flasks 
adopted a fibroblast-like morphology (Figure 3). 
These cells appeared to become more flattened and 
enlarge in size after several sequential passages. 
Until passage 4, an average of 25 days (up to 30 
days) of culturing was necessary. Considerable 
individual differences were observed in the number 
of isolated mononuclear cells and in the BM-pMSCs 
in each passage (Table 1).
The cells expressed the mesenchymal surface 
markers, CD29, CD44 and CD90, and did not 
express the hematopoietic markers, CD45, CD34 
and CD14. The cells also did not express MHC-II. 
The cell viability evaluated by 7-AAD was 97.3% 
(Figure 4).
The  BM-pMSCs exposed  to  med ium 
supplemented with differentiation factors were 
capable of differentiating into mesenchymal 
lineages, such as osteogenic, adipogenic, and 
chondrogenic. During osteogenic stimulation, BM-
pMSC continued to proliferate and readily formed 
multilayers showing differentiation along the 
osteogenic lineage. At day 21, after alizarin red 
staining, almost the whole cell layer was heavily 
covered with mineralized matrix. The adipogenic 
differentiation was confirmed by staining with oil 
red O, since the adipocytes were easily identified 
morphologically, by intracellular accumulation 
of neutral lipids. The chondrogenic potential of 
BM-pMSC was also characterized by alcian blue 
staining, after 21 of culturing, which revealed a 
homogeneous deposition of glycosaminoglycans. 
The control cells cultured during the same period in 
DMeM supplemented with 15% FBS did not exhibit 
spontaneous differentiation (Figure 5).
The higher gene expression of AP2, ALP and 
COLII in induced cells compared with non-induced 
cells also confirmed their potential to differentiate 
into adipocytes, osteoblasts and chondroblasts, 
with statistical significance (p<0.001, p<0.001 and 
p=0.031, respectively). The relative quantification 
of mRNA levels normalized to GAPDH was 
respectively for control and induced cells: 0.1 
Sample Isolated 
Mononuclear Cells
Passage 1 Passage 2 Passage 3 Passage 4
N cells Viability 
(%)
N cells Viability 
(%)
N cells Viability 
(%)
N cells Viability 
(%)
N cells Viability 
(%)
1 183.5x106 87.0 30.5x106 97.0 36.5x106 96.4 32.5x106 88.0 50.0x106 87.5
2 122.5x106 95.2 47.5x106 97.0 40.5x106 97.0 55.5x106 91.0 70.0x106 93.0
3 181.7x106 94.0 37.0x106 97.3 31.0x106 95.5 65.5x106 90.0 154.0x106 98.0
4 176.2x106 83.0 48.3x106 92.1 45.0x106 91.0 87.0x106 95.2 120.0x106 96.3
5 122.5x106 93.5 50.7x106 93.0 59.7x106 97.0 63.5x106 90.0 72.5x106 97.0
6 211.5x106 93.6 43.5x106 95.0 47.5x106 96.0 39.5x106 92.0 45.5x106 96.0
7 127.5x106 94.7 29.7x106 92.0 32.0x106 97.0 43.5x106 95.0 50.0x106 99.0
8 218.2x106 94.0 70.7x106 95.0 73.5x106 95.0 68.5x106 96.0 64.0x106 96.0
9 244.0x106 94.0  90.5x106 97.0  85.3x106 97.0  92.7x106 91.0 111.0x106 97.0
10 154.0x106 90.0 78.7x106 92.0  81.2x106 92.0  88.5x106 97.5 95.5x106 100.0
11 220.0x106 89.0  92.5x106 94.0  88.0x106 94.0  95.5x106 93.5 100.5x106 93.0
12 140.0x106 92.0  60.5x106 97.0 75.7x106 96.0  70.5x106 92.0 78.5x106 94.0
Average 183.5x106 91.7  56.7x106 94.9  58.0x106 95.3  66.9x106 92.6 84.3x106 95.5
SD 38.9x106 3.7  21.9x106 2.2  21.7x106 2.0  21.3x106 2.8  32.8x106 3.3
Table 1- Total number and viability of mononuclear cells isolated from bone marrow of minipig BR-1 and number and 
viability of mesenchymal stem cells in each passage
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and 1.2 (AP2), 1.0 and 13.7 (ALP), 1.0 and 1.7 
(COLII). The RT-PCR of each gene also showed a 
strong band in induced cells. The overall RT-PCR 
profile was very similar for the technical triplicates 
(Figure 6).
DISCUSSION
Great advances in tissue engineering have been 
obtained in large-animal models. The development 
of preclinical models in large animals requires 
the use of well-characterized animal cell lines 
similar to their human counterparts2. The use 
of miniature pigs in experimental research has 
advantages because this animal has characteristics 
and dimensions similar to the human body, 
bringing the experiences of clinical trials in human 
medicine15. Furthermore, minipigs have close 
similarities to humans in terms of platelet count, 
clotting parameters, metabolic rate, bone structure 
and MSCs characteristics2,10,11,15,17,20, providing 
good representation of individual patient-based 
investigations. The BR1 still has larger dimensions 
compared to Göttingen minipigs, but in Brazil the 
BR1 is the only breed developed exclusively for 
research. The Gottingen minipigs here in Brazil 
are rare to find and they are more expensive 
than the BR1. The advantage of using this breed 
Figure 4- A) Immunophenotypic analysis. Each value is the mean percentage of the twelve samples ± standard deviation 
of BM-pMSCs, which were tested for each cell surface antigen expression. B) BM-pMSCs were labeled with antibodies 
against the indicated antigens and analyzed by flow cytometry. Representative histograms are displayed. On the y axis, 
there is the % max (the cell count in each bin divided by the cell count in the bin that contained the largest number of 
cells), and the x axis is the fluorescence intensity in a log (100–104) scale. The isotype control is showed in red, and blue 
histogram indicates reactivity with the antibody indicated
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in comparison with conventional pigs is that they 
can weight 150 kg at 6 months. This makes them 
easier to handle during experimental work.
BM-MSCs have been isolated from many animal 
species and amplified in culture for various in vitro 
and in vivo applications1,4,20. The isolation and 
expansion of BM-pMSCs from BR-1 was feasible, 
using selected culture medium and protocols, 
as described for the isolation of human MSCs, 
as previously described by other authors16,17. 
Here, pMSC presented similar morphological 
features known from MSCs derived from other 
species14,16,17,20. Recently, other authors compared 
BM-MSCs from Göttingen minipigs and humans. 
MSCs were found in all minipig BM samples, but 
no circulating MSCs could be detected. Minipig BM-
MSCs had morphology, proliferation, and colony 
formation capacities similar to humans9.
As previously described by others, the techniques 
used for aspiration, isolation and osteogenic/
chondrogenic/adipogenic differentiation of human 
MSCs can be adopted for analysis of pMSC, which 
may serve the increasing demand for stem and 
progenitor cells in tissue engineering11,17. As a 
result of the presented similarities between porcine 
and human MSC, pMSCs are likely to be considered 
as a valuable model system for skeletal research.
One of the remaining major problems in 
characterizing MSCs from distinct animal models 
such as pigs is the lack of appropriate species-
specific MSCs marker molecules17. The cells had 
positive expression of known MSCs surface markers 
(CD90, CD29 and CD44) and negative expression 
of others (CD45, CD34 and CD14). The selection 
of markers for animal MSCs is challenging, since 
commercial markers are not available and not all 
human and murine antibodies cross-react with 
other species19. Because of the difficulty to obtain 
Figure 5- Differentiation of BM-pMSCs into osteoblasts (B), adipocytes (D) and chondrocytes (F) after 21 days of culturing 
in an induced medium, showing by Alizarin Red S, Oil Red O and Alcian Blue 8GX staining, respectively. Control cells were 
grown during the same period in a non-induced medium (A, C, E)
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Figure 6- Expression analyses of three markers of mesenchymal stem cells from minipig BR-1 differentiated to: adipocytes 
(AP2), osteoblasts (ALP) and chondroblasts (COLII). Differentiation was induced over a period of 21 days, RNA was 
purified and the levels of the specific mRNAs were assayed by RT-PCR. The expression of GAPDH was used as a control. 
Data were collected from cell cultures of 3 independent animals, and reverse transcriptase-polymerase chain reaction (RT-
PCR) reactions were carried out in technical triplicates, normalized to GAPDH. *p<0.05
commercial antibodies specific for minipigs, we 
used antibodies CD90 and CD34 against human 
antigens. The reactivity observed in BM-pMSCs 
with anti-human CD90 and CD34 antibodies was 
probably due to the cross-reaction with human 
antigens. The other antibodies used were specific 
for swine antigens CD14, CD44, CD45, CD29 and 
MHC-II. Our results are in agreement with an earlier 
study with BM-pMSCs, which reported a cellular 
viability of 90.0% and over 95.0% of cells positive 
for CD29, CD44 and CD9015. In a previous study, 
the authors isolated and characterized BM-pMSCs 
from Chinese miniature pigs and determined, by 
flow cytometry, the mean percentage of CD29 
(98.0%), CD44 (97.4%), CD34 (1.2%) and CD45 
(3.5%)8. These data corroborate our results, 
since the averages for the same antibodies were 
89.8%, 86.9%, 1.61% and 1.83%, respectively. 
In addition to MSCs related markers, in order to 
determine the potential immunogenicity of BM-
pMSCs, we performed the analysis of class II 
histocompatibility molecule. Similarly to humans, 
the BM-pMSCs showed a negative expression of 
MHC-II2.
Although the main source of MSCs is the BM, 
these cells constitute, however, only a small 
percentage of the total number of BM-populating 
cells. It is known that only 0.001% to 0.01% of 
mononuclear cells isolated on density gradient give 
rise to plastic adherent fibroblast-like colonies14. 
The number of MSCs isolated from this tissue 
may vary in terms of yield and quality, even when 
the cells are obtained from the same donor13. 
Regarding the volume of BM aspirate, the collection 
range is very large in the literature, varying from 
5 ml to more than 20 ml1,12,15,20. Thus, it is not 
necessary to collect a large amount of BM to 
acquire great numbers of MSCs. In the current 
study, an aspirate of 20 mL of BM allowed an 
average isolation of 9.2x106 mononuclear cells/
ml of BM aspirate. After 3–4 weeks of culture, 
the average quantity of pMSC was 84.3x106 with 
95.5% of cell viability. A similar study in minipigs 
described that 5 mL of BM aspirate is sufficient to 
obtain two million MSCs in 3 weeks of culture with 
a cell viability of 90%15. In another previous study 
with Japanese minipigs, the authors collected 20 
ml of BM from which pMSCs were isolated and 
expanded to a density of about 300x106 cells in 
one month of culture12. The proliferation of pMSCs 
during culture, within approximately 3–4 weeks 
until passage 4, indicates that this animal model 
is very attractive for preclinical trials.
Regarding the differentiation potential, it was 
demonstrated in our study that BM-pMSCs from 
BR1 differentiated into adipocytes, osteoblasts and 
chondroblasts after 21 days using protocols and 
commercial media for human MSCs differentiation16. 
Although we have not performed any comparison 
with human cells, the results indicate that the 
commercial media developed for the differentiation 
of human cells can be used for BR1 without 
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jeopardizing the outcome. The induced cells also 
showed higher gene expression of AP2, ALP and 
COLII, confirming their differentiation ability. These 
results support that BR1 can be used in preclinical 
trials in regenerative medicine like other breeds of 
minipigs8,17,20. A previous study showed that BM-
MSCs from Göttingen minipigs had a significantly 
lower ability than human BM-MSCs to differentiate 
into functional osteoblasts as demonstrated by a 
lower percentage von Kossa-positive staining and 
lower ALP activity9. This observation emphasizes 
the need for species-specific optimization of MSC 
culture protocol before direct comparisons of 
MSCs between human and various preclinical large 
animal models can be made.
Regarding the osteogenic differentiation, 
commercial medium containing dexamethasone, 
ß-glycerolphosphate and ascorbate was able to 
promote differentiation17. To promote adipogenic 
differentiation, pMSCs were treated with defined 
medium containing dexamethasone, insulin 
and indomethacin. Adipogenic induction was 
demonstrated by the accumulation of vacuoles 
filled with neutral lipids and by the induction of 
distinct adipogenic marker genes, as aP2, which 
is directly related to lipid metabolism7. Regarding 
the chondrogenic differentiation, pMSCs that 
were cultured with chondrogenic medium with 
TGF-ß developed typical morphologic features 
of mucopolysaccharide producing chondroblasts. 
Although the extracellular matrix protein collagen 
type ll was also expressed by pMSCs without 
differentiation induction, RT-PCR showed that its 
mRNA levels were higher in induced cells than in 
non-induced ones.
As ex vivo expansion of stem cells could 
lead to tumorigenic transformation, it has been 
recommended the monitoring of genetic stability 
during the culture, although the occurrence of 
aneuploid cells (with numerical chromosomal 
anomalies) is not necessarily associated with 
the transformation18. In this study, we did not 
perform karyotyping, but cells were continuously 
observed until passage 4 and had no sign of 
loss of proliferation potential, death or changes 
in morphology that could indicate apoptosis. A 
previous study recommended less than eight 
passages culture schedule to avoid senescence1. 
early passage pMSCs retained the multipotentiality, 
whereas the late passage MSCs retained only the 
adipogenic potential20.
CONCLUSIONS
The results show that the BM-MSCs of BR-
1, obtained with the protocol detailed in this 
manuscript, are MSCs, since they showed plastic-
adherence capacity, fibroblastic morphology, 
positive surface markers characteristic of MSCs, 
and potential to differentiate into adipocytes, 
osteoblasts and chondroblasts.
The establishment of isolation, cultivation 
and differentiation of BM-MSCs from BR-1 is a 
step forward to further preclinical research in 
Brazil. This breed has been proven to be a useful 
large-animal model for stem cell-based tissue 
engineering.
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